A double‐blind placebo‐controlled study of fluvoxamine and imipramine in out‐patients with primary depression.
Open Access
- 1 June 1983
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 15 (S3) , 433S-438S
- https://doi.org/10.1111/j.1365-2125.1983.tb02134.x
Abstract
1 A double-blind placebo-controlled study of fluvoxamine and imipramine was performed in a group of depressed patients. Twenty-two patients received fluvoxamine (mean dose 101 mg/day), 25 received imipramine (mean dose 127 mg/day) and 22 received placebo. 2 Apart from an increase in the SGOT and SGPT values of four imipramine patients, no statistically significant changes in haematology or urinalysis were judged to be medically relevant. Fluvoxamine exhibited fewer anticholinergic side effects than imipramine. 3 Both fluvoxamine treated patients and imipramine-treated patients exhibited a statistically significant improvement at the end of the 28-day treatment period with respect to the placebo patients, as measured using the Hamilton Rating Scale for Depression, and the Clinical Global Impression Scale. Evaluations of the results of the Beck Depression Inventory and the Profile of Mood States revealed a statistically significant improvement for imipramine patients with respect to placebo at week 4, but not for fluvoxamine patients. It is postulated on the basis of quantitative pharmaco-EEG findings, that the slight superiority of imipramine over fluvoxamine was due to underdosing of the latter.Keywords
This publication has 11 references indexed in Scilit:
- Quantitative Pharmaco-ElectroencephalographyPublished by S. Karger AG ,2015
- FLUVOXAMINE, A SPECIFIC 5‐HYDROXYTRYPTAMINE UPTAKE INHIBITORBritish Journal of Pharmacology, 1977
- Biogenic Amines and DepressionArchives of General Psychiatry, 1975
- Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram.1975
- "Psychotropic" action of sex hormones: computerized EEG in establishing the immediate CNS effects of steroid hormones.1974
- Assessment of Depression: The Depression InventoryPublished by S. Karger AG ,1974
- SCH-12,041, a new anti-anxiety agent (quantitative pharmaco-electroencephalography and clinical trials).1972
- Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).1972
- Abnormalities of Indoleamines in Affective DisordersArchives of General Psychiatry, 1972
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967